Prevalence and causes of blindness & low vision; before and five years after 'VISION 2020' initiatives in Oman: A review

Ophthalmic Epidemiology

Volumn 14, Issue 1, 2007, Pages 9-15

  Khandekar, Rajiv ^a   Mohammed, Ali Jaffer ^a   Raisi, Abdulatif Al ^b  

^a MINISTRY OF HEALTH   (Oman)

^b Al Nahdhah Hospital   (Oman)

Author keywords

Blindness prevalence; Oman; Sow vision; Underdeveloped countries; Vision 2020; Vision impairment

Indexed keywords

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; BLINDNESS; CATARACT; CONTROLLED STUDY; CORNEA; DIABETIC RETINOPATHY; EYE FUNDUS; FEMALE; GLAUCOMA; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OMAN; OUTCOME ASSESSMENT; PATHOLOGY; POPULATION DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPECTACLES; VISUAL DISORDER;

ADULT; AGE DISTRIBUTION; AGED; BLINDNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OMAN; PREVALENCE; SEX DISTRIBUTION; VISION, LOW;

EID: 33847353311     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580600864802     Document Type: Article

References (29)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004;82(11):844-851.
2. Khandekar R, Mohammed AJ, Negrel AD, Riyami AA. The prevalence and causes of blindness in the Sultanate of Oman: TheOman Eye Study (OES). Br J Ophthalmol. 2002;86(9):957-962.
3. Ministry of Health, Sultanate of Oman. Blindness Survey Report; Oman Eye Study (OES). Muscat, Oman: Mazoon Printing Press, 1998; 15-20.
4. Report on the conference on 'VISION 2020. Planning for the Eastern Mediterranean Region'. Cairo, Egypt: World Health Organization, 2003. (WHO/EMR/PBL/03.1) (http://whilibdoc.who.EMR/2003/WHO PBL/03.1 pdf).
5. Ministry of Health, Sultanate of Oman. Eye Health Care Manual, 2nd ed. Muscat, Oman: Al Zahra Printers, 2000; 6-7.
6. Ministry of National Economy, Sultanate of Oman. Census 2003. A monthly bulletin issued by the Administration of the 2003 census, 13th ed. Oman: Ministry of National Economy, 2004; 20.
7. Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2003. Muscat, Oman: Al Zahra Printers, 2004; 1-4.
8. World Health Organization. World Health Report 2000. Health systems: Improving performance. Geneva: WHO, 2000; 200 pp.
9. World Health Organization. Prevention of Blindness & Deafness. Consultation on Development of Standards for Characterization of Vision loss & Visual Functioning. Geneva: WHO, 2003 (WHO/PBL/03.91); 9 pp.
10. Courtright P, Hoechsmann A, Metcalfe N, et al. Changes in blindness prevalence over 16 years in Malawi: reduced prevalence but increased numbers of blind. Br J Ophthalmol. 2003;87(9):1079-1082.
11. Khandekar R, Mohammed A. Cataract prevalence, cataract surgical coverage and its contribution to the reduction of visual disability in Oman. Ophthalmic Epidemiol. 2004;11(3):181-189.
12. Lewallen S, Courtright P. Gender and use of cataract surgical services in developing countries. Bull WHO. 2002;80(4):300-303.
13. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
14. Buch H, Vinding T, La Cour M, et al. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004;111(1):53-61.
15. Rothe Nissen K, Sjolie AK, Jensen H, et al. The prevalence and incidence of visual impairment in people of age 20-59 years in industrialized countries: a review. Ophthalmic Epidemiol. 2003;10(4):279-291.
16. Chen JH, Xu L, Hu AL, et al. Prevalence of low vision and blindness in defined populations in rural and urban areas in Beijing. Zhonghua Yixue Zazhi. 2003;83(16):1413-1418.
17. Fotouhi A, Hashemi H, Mohammad K, Jalali KH; The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study. Br J Ophthalmol. 2004;88(6):740-745.
18. Dineen BP, Bourne RR, Ali SM, Huq DM, Johnson GJ. Prevalence and causes of blindness and visual impairment in Bangladeshi adults: Results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol. 2003;87(7):820-828.
19. Sulaiman Ali JM, Al Riyami A, Farid SM. Family Health Survey. ISBN 9960-15-098-4; 60-61.
20. Eye Health Care Program, Ministry of Health, Oman & Eye Health Care Manual, 1st Edition, UNICEF, 1995; 2-6.
21. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003;26(6):1781-1785.
22. Rajab A, Patton MA. A study of consanguinity in the Sultanate of Oman. Ann Hum Biol. 2000;27(3):321-326.
23. Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2004. Muscat, Oman: Al Zahra Printers, 2005; 8-48.
24. Kocure I. Vision 2020 and Disease control priorities and cataract. In: Implementation of VISION 2020 in the Eastern Mediterranean Region-Report on a regional planning workshop. (WHOEM/CPB/001/E). World Health Organization, 2003.
25. Khandekar R. Cataract Fortnight in Oman-A Report. Community Health & Disease Surveillance Newsletter. 1998; 7(4):8. htpp://www.emro.who. info/CountryProfiles-oma-news.htm
26. Thylefors B, Negrel A-D, Parajasegaram R, Dadzie KY. Global data on blindness. Bull WHO. 1995;73(1):115-121.
27. Khandekar R, Mohammed AJ. Visual disabilities among diabetics in Oman. Saudi Med J. 2005;26(5):836-841.
28. Taylor HR. Cataract: How much surgery do we have to do? Br J Ophthalmol. 2000;84:1-2.
29. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye. 2005;19(10):1133-1135